Medicare Enrolled
Dr. Neil Faulkner, M.D., PH.D.
Hematology & Oncology · Tipton, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Faulkner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Faulkner?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Faulkner
Dr. Neil Faulkner is a hematology & oncology specialist in Tipton, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Faulkner performed 313 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Faulkner received a total of $14,567 from 86 pharmaceutical and/or device companies across 864 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Faulkner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 313 Medicare services
$14,567 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗313
Medicare services
Bottom 23% in MI for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
104 | $107 | $420 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $69 | $303 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
43 | $50 | $215 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
40 | $90 | $240 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
31 | $127 | $470 |
| New patient office visit, complex (60-74 min) | 23 | $136 | $520 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$14,567
Total received (2018-2024)
Avg $2,081/year across 7 years
Top 12% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
864
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,750
2023
$2,592
2022
$1,853
2021
$977
2020
$854
2019
$3,035
2018
$2,506
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$257
Merck Sharp & Dohme LLC
$192
AstraZeneca Pharmaceuticals LP
$190
PFIZER INC.
$180
Janssen Biotech, Inc.
$169
Regeneron Healthcare Solutions, Inc.
$142
Novartis Pharmaceuticals Corporation
$130
ABBVIE INC.
$112
GlaxoSmithKline, LLC.
$104
Genentech USA, Inc.
$102
EMD Serono, Inc.
$87
Incyte Corporation
$81
SpringWorks Therapeutics, Inc.
$69
Ipsen Biopharmaceuticals, Inc
$67
Eisai Inc.
$65
Deciphera Pharmaceuticals Inc.
$63
Lilly USA, LLC
$61
Tempus AI, Inc
$57
Gilead Sciences, Inc.
$53
Daiichi Sankyo Inc.
$52
INTUITIVE SURGICAL, INC.
$52
Celgene Corporation
$49
Takeda Pharmaceuticals U.S.A., Inc.
$47
Aveo Pharmaceuticals, Inc.
$41
Astellas Pharma US Inc
$35
Bayer Healthcare Pharmaceuticals Inc.
$32
GENZYME CORPORATION
$27
Kite Pharma, Inc.
$25
TerSera Therapeutics LLC
$25
Exelixis Inc.
$24
Genmab U.S., Inc.
$24
SERVIER PHARMACEUTICALS LLC
$22
JAZZ PHARMACEUTICALS INC.
$21
RECORDATI_RARE_DISEASES_INC.
$21
Boston Scientific Corporation
$20
Coherus Biosciences Inc.
$18
Tolmar, Inc.
$17
ARRAY BIOPHARMA INC
$14
Rigel Pharmaceuticals, Inc.
$5
Top 3 companies account for 23.2% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$1,657
E.R. Squibb & Sons, L.L.C.
$1,371
Amgen Inc.
$1,064
Novartis Pharmaceuticals Corporation
$978
Merck Sharp & Dohme Corporation
$707
PFIZER INC.
$692
Regeneron Healthcare Solutions, Inc.
$639
AstraZeneca Pharmaceuticals LP
$613
Merck Sharp & Dohme LLC
$514
Celgene Corporation
$345
Seagen Inc.
$344
GENZYME CORPORATION
$343
Janssen Biotech, Inc.
$327
Gilead Sciences, Inc.
$281
Daiichi Sankyo Inc.
$255
EMD Serono, Inc.
$247
Incyte Corporation
$224
Lilly USA, LLC
$221
GlaxoSmithKline, LLC.
$211
Takeda Pharmaceuticals U.S.A., Inc.
$206
Exelixis Inc.
$182
Ipsen Biopharmaceuticals, Inc
$167
Boehringer Ingelheim Pharmaceuticals, Inc.
$157
ABBVIE INC.
$155
Eisai Inc.
$153
EISAI INC.
$141
Seattle Genetics, Inc.
$120
Deciphera Pharmaceuticals Inc.
$117
Astellas Pharma US Inc
$116
Bayer HealthCare Pharmaceuticals Inc.
$109
Aadi Bioscience, Inc.
$99
Mirati Therapeutics, Inc.
$98
JAZZ PHARMACEUTICALS INC.
$94
BeiGene USA, Inc.
$83
TESARO, Inc.
$71
SpringWorks Therapeutics, Inc.
$69
Pharmacyclics LLC, An AbbVie Company
$67
ARRAY BIOPHARMA INC
$65
Alexion Pharmaceuticals, Inc.
$63
Sun Pharmaceutical Industries Inc.
$61
Rigel Pharmaceuticals, Inc.
$59
Tempus AI, Inc
$57
INTUITIVE SURGICAL, INC.
$52
Bayer Healthcare Pharmaceuticals Inc.
$49
Karyopharm Therapeutics Inc.
$45
Coherus Biosciences Inc.
$45
Aveo Pharmaceuticals, Inc.
$41
Foundation Medicine, Inc.
$38
Jazz Pharmaceuticals Inc.
$38
AbbVie, Inc.
$34
Alnylam Pharmaceuticals Inc.
$33
Blueprint Medicines Corporation
$31
MorphoSys, US Inc.
$31
Puma Biotechnology, Inc.
$26
Kite Pharma, Inc.
$25
TerSera Therapeutics LLC
$25
Agios Pharmaceuticals, Inc.
$24
Genmab U.S., Inc.
$24
Biocompatibles, Inc.
$24
MACROGENICS, INC.
$23
G1 Therapeutics, Inc.
$22
Immunocore Limited
$22
SERVIER PHARMACEUTICALS LLC
$22
RECORDATI_RARE_DISEASES_INC.
$21
KCI USA, Inc
$20
Novo Nordisk Inc
$20
AVEO Pharmaceuticals, Inc.
$20
Boston Scientific Corporation
$20
AbbVie Inc.
$20
Acceleron Pharma, Inc.
$19
Pharming Healthcare, Inc.
$18
Tolmar, Inc.
$17
Kyowa Kirin, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$15
Pharmacosmos Therapeutics Inc.
$15
Adaptive Biotechnologies Corporation
$14
Pharmacyclics LLC, an AbbVie Company
$14
TAIHO ONCOLOGY, INC.
$14
Verastem, Inc.
$13
Taiho Oncology, Inc.
$12
Janssen Scientific Affairs, LLC
$12
Epizyme, Inc.,
$12
Otsuka America Pharmaceutical, Inc.
$11
Helsinn Therapeutics (U.S.), Inc.
$11
INSYS Therapeutics Inc
$11
NOVARTIS PHARMACEUTICALS CORPORATION
$10
Top 3 companies account for 28.1% of all-time payments
Associated products mentioned in payments ›
ABTHERA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AMVUTTRA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · Da Vinci Surgical System · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Epkinly · Erivedge · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fyarro · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMLYGIC · INJECTAFER · INLYTA · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LARTRUVO · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · Lenvima · Lonsurf · Lunsumio · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MVASI · Morphabond ER · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · ODOMZO · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · Odomzo · Onivyde · PADCEV · PANHEMATIN · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · ROZLYTREK · RUCONEST · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · SANDOSTATIN · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · SpaceOAR VUE System - 10mL · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · THERASPHERE - BIO · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Voranigo · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · YERVOY · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
2
County median income
$67,013
Nearest hospital to ZIP centroid (approximate)
PROMEDICA CHARLES AND VIRGINIA HICKMAN HOSPITAL
8.4 mi
8.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Faulkner is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Faulkner experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Faulkner performed 104 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Faulkner receive payments from pharmaceutical companies?
Yes. Dr. Faulkner received a total of $14,567 from 86 companies across 864 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Faulkner's costs compare to other hematology & oncology specialists in Tipton?
Dr. Faulkner's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Faulkner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Tipton
Browse hematology & oncology specialists in Tipton ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology